2017, Number 1
<< Back Next >>
Gac Med Mex 2017; 153 (1)
Diffuse cutaneous leishmaniasis (DCL) and visceral leishmaniasis (VL) concurrent with cancer: Presentation of a case
Blum-Domínguez SC, Martínez-Vázquez A, Núñez-Oreza LA, Martínez-Hernández F, Villalobos G, Tamay-Segovia P
Language: Spanish
References: 15
Page: 121-124
PDF size: 168.91 Kb.
ABSTRACT
Male of 52 year old with chronic alcoholism and ulcerated lesion on the face and disseminated nodular skin lesions, underwent
to biopsy of ulcer edges where was observed a concomitant epidermoid malignancy with Leishmania (L.). Besides
others, biopsies of nodule in the periumbilical region, lymph node and bone marrow were assayed, and all biopsies had
abundant amastigotes. The amplified Polymerase Chain Reaction (PCR) products from nodule were sequenced and the
alignment analysis demonstrated homology with L. mexicana confirming the infection by this parasite. This is considered the
first case of visceral and diffuse cutaneous leishmaniasis concurrent with epidermoid cancer in the state of Campeche.
REFERENCES
World Health Organization. Control of the leishmaniases. World Health Organ Tech Rep Ser. 2010;949:1-186.
Puig L, Pradinaud R. Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol. 2003;97 Suppl 1:107-14.
Mercé-Alsina M, Llambrich-Mañes A. Leishmaniasis en pacientes infectados por el VIH. Piel. 2002;17:208-13.
Santos-Oliveira JR, Da-Cruz AM, Pires LH, et al. Case Report: Atypical Lesions as a Sign of Cutaneous Dissemination of Visceral Leishmaniasis in a Human Immunodeficiency Virus–Positive Patient Simultaneously Infected by Two Viscerotropic Leishmania Species. Am J Trop Med Hyg. 2011;85:55-9.
Chaudhary RG, Bilimoria FE, Katare SK. Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV). Indian J Dermatol Venereol Leprol. 2008;74:641-3.
Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305-18.
Cref BJ, Jones TC, Badar R, Sampaio D, Teixeira R, Johnson WDJ. Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis. 1987;156:1030-3.
Peniche J. Tumores de la piel. En: Saúl A. Lecciones de Dermatología. México D.F., México: Francisco Méndez Cervantes Ed.; 2000.
Karabekmez FE, Duymaz A, Keskin M, Tosun Z. Squamous Cell Carcinoma on Cutaneous Leishmaniasis Lesion. Dermatol Surg. 2008;34:1742-3.
Bosch RJ, Rodrigo AB, Sánchez P, De Gálvez MV, Herrera E. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol. 2002; 41:670-5.
Pérez C, Solías Y, Rodríguez G. Leishmaniasis cutánea difusa en un paciente con SIDA. Biomédica. 2006;26:485-97.
Monroy-Ostria A, Sanchez-Tejeda G. Molecular probes and the polymerase chain reaction for detection and typing of Leishmania species in Mexico. Trans R Soc Trop Med Hyg. 2002;96:s101-4.
Monroy-Ostria A, Nasereddin A, Monteon VM, Guzmán-Bracho C, Jaffe CL. ITS1 PCR-RFLP Diagnosis and Characterization of Leishmania in Clinical Samples and Strains from Cases of Human Cutaneous Leishmaniasis in States of the Mexican Southeast. Interdiscip Perspect Infect Dis. 2014;2014:607287.
Ordaz-Farias A, Muñoz-Garza FZ, Sevilla-Gonzalez FK, et al. Case Report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana. Am J Trop Med Hyg. 2013;88:153-6.
Pascual I, Monasterio S, González-Obeso E, Corripio R, Martínez J, Pérez-Robledo JP. Abdomen agudo en paciente VIH por Leishmaniasis visceral. Rev Esp Enferm Dig. 2007;99:49-60.